A whey protein supplement decreases post-prandial glycemia

Brent L Petersen, Loren S Ward, Eric D Bastian, Alexandra L Jenkins, Janice Campbell, Vladimir Vuksan, Brent L Petersen, Loren S Ward, Eric D Bastian, Alexandra L Jenkins, Janice Campbell, Vladimir Vuksan

Abstract

Background: Incidence of diabetes, obesity and insulin resistance are associated with high glycemic load diets. Identifying food components that decrease post-prandial glycemia may be beneficial for developing low glycemic foods and supplements. This study explores the glycemic impact of adding escalating doses of a glycemic index lowering peptide fraction (GILP) from whey to a glucose drink.

Methods: Ten healthy subjects (3M, 7F, 44.4 +/- 9.3 years, BMI 33.6 +/- 4.8 kg/m2) participated in an acute randomised controlled study. Zero, 5, 10 and 20 g of protein from GILP were added to a 50 g glucose drink. The control (0 g of GILP) meal was repeated 2 times. Capillary blood samples were taken fasting (0 min) and at 15, 30, 45, 60, 90 and 120 minutes after the start of the meal and analyzed for blood glucose concentration.

Results: Increasing doses of GILP decreased the incremental areas under the curve in a dose dependant manner (Pearson's r = 0.48, p = 0.002). The incremental areas (iAUC) under the glucose curve for the 0, 5, 10, and 20 g of protein from GILP were 231 +/- 23, 212 +/- 23, 196 +/- 23, and 138 +/- 13 mmol.min/L respectively. The iAUC of the 20 g GILP was significantly different from control, 5 g GILP and 10 g GILP (p < 0.001). Average reduction in the glucose iAUC was 4.6 +/- 1.4 mmol.min/L per gram of ingested GILP.

Conclusion: Addition of GILP to a oral glucose bolus reduces blood glucose iAUC in a dose dependent manner and averages 4.6 +/- 1.4 mmol.min/L per gram of GILP. These data are consistent with previous research on the effect of protein on the glycemic response of a meal.

Figures

Figure 1
Figure 1
Incremental blood glucose response after meals containing either glucose alone (control), or glucose plus either 5, 10 or 20 g of protein from GILP. Data are expressed as Mean ± SEM. * 20 g GILP meal significantly different from control, ** 20 g GILP different from 5 g GILP and control, *** 20 g GILP different from all meals using GLM ANOVA and adjusted for multiple pair-wise comparisons with the Tukey-Kramer test (p < 0.001).
Figure 2
Figure 2
Correlation of blood glucose iAUC with amount of ingested protein after meals containing either 50 g of glucose alone (0 protein), or 50 g of glucose plus 5, 10 or 20 g of protein from GILP (p = 0.002).

References

    1. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS. A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med. 2003;157:773–779. doi: 10.1001/archpedi.157.8.773.
    1. Salmerón J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes care. 1997;20:545–550. doi: 10.2337/diacare.20.4.545.
    1. Van Dam RM, Visscher AEJ, Feskens EJM, Verhoef P, Kromhout D. Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study. Euro Journal Clin Nutr. 2000;54:726–731. doi: 10.1038/sj.ejcn.1601086.
    1. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002;75:492–498.
    1. Augustin LSA, Polesel J, Bosetti C, Kendall CWC, La Vecchia C, Parpinel M, Conti E, Montella M, Franceschi S, Jenkins DJA, Dal Maso L. Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy. Ann Oncol. 2003;14:78–84. doi: 10.1093/annonc/dkg022.
    1. Franceschi S, Dal Maso L, Augustin L, Negri E, Parpinel M, Boyle P, Jenkins DJA, La Vecchia C. Dietary glycemic load and colorectal cancer risk. Ann Oncol. 2001;12:173–178. doi: 10.1023/A:1008304128577.
    1. Brand JC, Nicholson PL, Thorburn AW, Truswell AS. Food processing and the glycemic index. Am J Clin Nutr. 1985;42:1192–1196.
    1. Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr. 2004;80:1246–1253.
    1. Ostman EM, Elmstahl HGML, Bjorck IME. Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr. 2001;74:96–100.
    1. Liljeberg Elmstahl H, Bjorck I. Milk as a supplement to mixed meals may elevate postprandial insulinaemia. Euro Journal Clin Nutr. 2001;55:994–999. doi: 10.1038/sj.ejcn.1601259.
    1. Zawadzki KM, Yaspelkis BB, Ivy JL. Carbohydrate-protein complex increases the rate of muscle glycogen storage after exercise. J Appl Physiol (Bethesda, Md: 1985) 1992;72:1854–1859.
    1. Van Loon LJC, Kruijshoop M, Verhagen H, Saris WHM, Wagenmakers AJM. Ingestion of protein hydrolysate and amino acid-carbohydrate mixtures increases postexercise plasma insulin responses in men. J Nutr. 2000;130:2508–2513.
    1. Schmid R, Schusdziarra V, Schulte-Frohlinde E, Maier V, Classen M. Effect of CCK on insulin, glucagon, and pancreatic polypeptide levels in humans. Pancreas. 1989;4:653–661. doi: 10.1097/00006676-198912000-00001.
    1. Krebs M, Brehm A, Krssak M, Anderwald C, Bernroider E, Nowotny P, Roth E, Chandramouli V, Landau BR, Waldhäusl W, Roden M. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia. 2003;46:917–925. doi: 10.1007/s00125-003-1129-1.
    1. Wolever TMS, Jenkins DJA, Jenkins AL, Josse RG. The glycemic index: methodology and clinical implications. Am J Clin Nutr. 1991;54:846–854.
    1. Schenk S, Davidson CJ, Zderic TW, Byerley LO, Coyle EF. Different glycemic indexes of breakfast cereals are not due to glucose entry into blood but to glucose removal by tissue. Am J Clin Nutr. 2003;78:742–748.
    1. Layman DK. The role of leucine in weight loss diets and glucose homeostasis. J Nutr. 2003;133:261S–267S.
    1. Rocha DM, Faloona GR, Unger RH. Glucagon-Stimulating Activity of 20 Amino Acids in Dogs. J Clin Invest. 2004;51:2346–2351. doi: 10.1172/JCI107046.
    1. Gunnarsson PT, Winzell MS, Deacon CF, Larsen MO, Jelic K, Carr RD, Ahren B. Glucose-Induced Incretin Hormone Release and Inactivation Are Differently Modulated by Oral Fat and Protein in Mice. Endocrinology. 2006;147:3173–3180. doi: 10.1210/en.2005-1442.
    1. Drucker DJ. Enhancing the Action of Incretin Hormones: A New Whey Forward? Endocrinology. 2006;147:3171–3172. doi: 10.1210/en.2006-0494.
    1. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and B-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002;359:824–830. doi: 10.1016/S0140-6736(02)07952-7.
    1. Takasaki K, Nakajima T, Ueno K, Nomoto Y, Higo K. Effects of combination treatment with dipeptidyl peptidase IV inhibitor and sulfonylurea on glucose levels in rats. J Pharmacol Sci. 2004;95:291–293. doi: 10.1254/jphs.SC0040043.

Source: PubMed

3
Iratkozz fel